BFM
JBIO

Boothbay Fund Management’s Jade Biosciences JBIO Stock Holding History

Boothbay Fund Management’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.97M Buy
139,968
+58,820
+72% +$852K 0.03% 631
2025
Q4 		$1.25M Buy
+81,148
New +$952K 0.02% 722
2024
Q4 		– Sell
-2,795
Closed -$204K – 1495
2024
Q3 		$204K Sell
2,795
-358
-11% -$23.1K ﹤0.01% 1393
2024
Q2 		$183K Buy
3,153
+358
+13% +$237K ﹤0.01% 1303
2024
Q1 		$2.89M Buy
+2,795
New +$2.13M 0.06% 384
2023
Q2 		– Sell
-1,131
Closed -$798K – 1808
2023
Q1 		$798K Buy
1,131
+393
+53% +$326K 0.02% 1095
2022
Q4 		$756K Sell
738
-284
-28% -$206K 0.02% 1015
2022
Q3 		$593K Buy
+1,022
New +$682K 0.01% 1140

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Boothbay Fund Management's JBIO Position: Q1 2026 in Review

Boothbay Fund Management increased its Jade Biosciences (JBIO) stake by 72% in Q1 2026, buying an estimated $852K and bringing the position to 139,968 shares worth $1.97M. The position accounts for 0.03% of the portfolio, ranked #631.

Boothbay Fund Management first reported a position in JBIO in Q3 2022 and has held it in 8 quarters since. The position peaked at $2.89M in Q1 2024. 120 funds tracked by Wall St. Rank hold JBIO as of Q1 2026.

  • Boothbay Fund Management held 139,968 shares of Jade Biosciences worth $1.97M as of Q1 2026.
  • Boothbay Fund Management bought 58,820 Jade Biosciences shares in Q1 2026, an estimated $852K.
  • Jade Biosciences made up 0.03% of Boothbay Fund Management's portfolio in Q1 2026, its #631 holding.
  • Boothbay Fund Management first reported a position in Jade Biosciences in Q3 2022 and has held it in 8 quarters since.
  • Boothbay Fund Management's Jade Biosciences position peaked at $2.89M in Q1 2024.
  • 120 funds tracked by Wall St. Rank held Jade Biosciences as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.